Comment

Comment by Dr. Krishna Kumari Challa 4 hours ago

What should you do with unused or expired prescription medications?

Unused or expired prescription medications should be disposed of promptly to prevent accidental ingestion, especially by children. Preferred disposal methods include take-back programs at pharmacies, police stations, or DEA events. If these are unavailable, mix medications with unpalatable substances before discarding in the trash. Some drugs, mainly opioids, may be flushed per FDA guidance. Sharps require separate disposal.

If you have unused or expired medication, the best thing is to dispose of it. Many people hang on to them, and this just creates opportunity for things to go wrong.

https://medicalxpress.com/news/2026-01-unused-expired-prescription-...

Comment by Dr. Krishna Kumari Challa 4 hours ago

Small number of 'highly plastic' cancer cells drive disease progression and treatment resistance
A small subset of highly plastic cancer cells, capable of shifting identity and behavior, drives tumor progression and treatment resistance. These cells, which increase in prevalence as tumors advance, exploit injury-repair programs and can survive therapies by adapting rapidly. Targeting them, for example via uPAR-directed CAR T cells, significantly impairs tumor growth and may enhance treatment efficacy.

In healthy tissues, stem cells make new cells to replace those that are lost or damaged through normal wear and tear.

Most organs maintain themselves with resident stem cells tailored to that type of tissue—alveoli or bronchial cells in the lung, skin cells, intestinal cells, and so on.

But when an injury occurs, special injury repair programs get triggered that put stem cells in an even more flexible state—"like a super stem cell." This allows the cell to expand its capabilities and produce a much wider variety of new cells.

The problem is when cancer cells borrow these programs that are normally only available to stem cells.

Indeed, it's these highly flexible—highly plastic—cell states related to injury repair that cancer hijacks. Highly plastic cells become more abundant as these tumors grow,  researchers found. 

These highly plastic cells aren't necessary to initiate a tumor. But they're critical to cancer's progression, the team found—including its ability to give rise to fast-growing cells, to evolve resistance to treatment, and to potentially help the cancer spread to other parts of the body.

If we kill off these plastic cells very early in the initiation of a tumor, you can basically prevent mutated cells from ever becoming cancers, say teh researchers.

Tuomas Tammela, Critical role for a high-plasticity cell state in lung cancer, Nature (2026). DOI: 10.1038/s41586-025-09985-x. www.nature.com/articles/s41586-025-09985-x

Comment by Dr. Krishna Kumari Challa 5 hours ago

Strikingly, these same genetic variants that influence the risk of pregnancy loss are also associated with recombination, the genetic shuffling process that generates diversity when eggs and sperm are made, they found.

Female meiosis, or the cell division necessary for reproduction, begins during fetal development, when chromosomes pair and recombine. The process then pauses for decades, until ovulation and fertilization. During this long pause, problems in the machinery that keeps chromosomes together can cause them to separate too soon, leading to an abnormal chromosome count when meiosis resumes.
The results demonstrate that inherited differences in these meiotic processes contribute to natural variation in risk of aneuploidy and pregnancy loss between individuals.

Rajiv McCoy, Common variation in meiosis genes shapes human recombination and aneuploidy, Nature (2026). DOI: 10.1038/s41586-025-09964-2. www.nature.com/articles/s41586-025-09964-2

Part 2

Comment by Dr. Krishna Kumari Challa 5 hours ago

Maternal genetic factors may reveal why pregnancy loss is so common

Pregnancy loss in humans is common, with about 15% of recognized pregnancies resulting in miscarriage and many more conceptions being lost at early stages without people realizing it.
Analysis of genetic data from nearly 140,000 IVF embryos demonstrates that common maternal genetic variants, particularly in genes involved in chromosome cohesion and recombination, contribute to individual differences in the risk of pregnancy loss due to chromosomal errors. These findings clarify molecular pathways underlying aneuploidy and suggest potential targets for future therapies.

By studying genetic data from nearly 140,000 IVF embryos, scientists have with unprecedented detail revealed why fewer than half of human conceptions survive to birth. The research uncovered the strongest evidence yet for how common genetic differences leave some individuals more vulnerable to pregnancy loss.

The vast dataset allowed the  team to demonstrate robust connections between specific variations in a mother's DNA and their risk of miscarriage.

The findings shed new light on human reproduction and suggest pathways for developing treatments to lower the risk of pregnancy loss.

Most chromosome errors originate in the egg and increase in frequency with a mother's age. More mysterious is how factors beyond age, such as genetic differences, may predispose a person to produce eggs with abnormal numbers of chromosomes in the first place.

Figuring that out requires analyzing genetic data from large numbers of embryos before pregnancy loss, as well as their biological parents.

The strongest associations appear in genes that govern how chromosomes pair, recombine, and are held together during egg formation, including a gene (SMC1B) that encodes part of the ring-shaped structure that encircles and binds chromosomes, the team found. These rings are essential for accurate chromosome segregation and tend to break down as women age.

Part 1

Comment by Dr. Krishna Kumari Challa 6 hours ago

What the brain's shape and complexity say about a newborn's development

The neonatal period, which is defined as the first 28 days after birth, is known to be a crucial stage in the development of the human brain. During this stage, the brain is known to grow significantly in size, with billions of new connections forming between neurons and supporting basic physiological functions.

Researchers recently carried out a study aimed at further exploring how the human brain's overall shape and size as well as the dimensions of distinct regions are linked to a newborn's development and maturity. Their findings, published in Nature Neuroscience, suggest that the brain's shape is a key marker of development during the neonatal period.

They analyzed publicly available magnetic resonance imaging (MRI) data collected from almost 800 human newborns as part of the developing Human Connectome Project (dHCP). Employing a mathematical method called fractal analysis, they tried to delineate the shape of the newborns' brains.

This approach yields a geometric measure called fractal dimensionality (FD) that describes the shape of a brain region in terms of its structural complexity.

Brain shape predicted the infants' ages significantly better than brain size, say teh researchers. Moreover, brain shape captured signatures of premature birth that were not detected with brain size.

They found that the brains of infants who were related to each other, such as twins, were more similar in shape than those of unrelated infants. The shape of the brains of identical twins, who share almost 100% of genes, was found to be more similar than those of fraternal twins, who share approximately 50% of genes.

Based on this relationship, the researchers were able to predict which babies are twin siblings from their brain shapes with high accuracy (~77% overall, ~97% in identical twins), again outperforming all other studied brain measures.

These results suggest that the early-life formation of brain shape represents a fundamental maturational process in human brain development.

Stephan Krohn et al, Fractal analysis of brain shape formation predicts age and genetic similarity in human newborns, Nature Neuroscience (2025). DOI: 10.1038/s41593-025-02107-w

Comment by Dr. Krishna Kumari Challa yesterday

Cancer patients warned popular supplement may interfere with treatment

Biotin supplements, commonly used by cancer patients to address hair loss, lack strong evidence for promoting hair or nail regrowth and can interfere with lab tests, potentially leading to inaccurate results and delayed or altered treatment. Biotin may cause false readings in tests for prostate, thyroid, ovarian, and breast cancers. Minoxidil is a safer, effective alternative for hair loss.

Layna Mager et al, Biotin Supplements for Hair and Nail Regrowth: A Caution for Oncologists, JCO Oncology Practice (2025). DOI: 10.1200/op-25-00693

Cancer patients warned popular supplement may interfere with treatment

Comment by Dr. Krishna Kumari Challa yesterday

Certain antibiotics may may boost immune system
Fluoroquinolone antibiotics can directly alter macrophage metabolism by stressing their mitochondria, leading to increased production of nitric oxide and enhanced bacterial clearance. This effect is specific to certain younger macrophage subsets in the lung and gut. While these antibiotics may boost immune cell function, they also carry risks such as microbiome disruption and potential tissue damage from excessive inflammation.

Alexander W Hardgrave et al, Fluoroquinolones directly drive mitochondrial hyperpolarization and modulate iNOS expression in monocyte-derived macrophage populations, Discovery Immunology (2025). DOI: 10.1093/discim/kyaf018

**

Comment by Dr. Krishna Kumari Challa yesterday

Chronic kidney disease poisons patients' hearts, scientists discover

Scientists have discovered an answer to the longstanding mystery of why more than half of patients with chronic kidney disease ultimately die of cardiovascular problems: Their kidneys produce a substance that poisons the heart.

Chronic kidney disease leads to the production of circulating extracellular vesicles in the kidneys, which carry toxic miRNA that harm the heart. Blocking these vesicles in animal models improved heart function. This mechanism may enable earlier identification and targeted treatment of heart failure risk in CKD patients.

The researchers say the discovery could let doctors identify people at risk and develop new treatments to help prevent and treat heart failure for these patients.

Xisheng Li et al, Circulating Extracellular Vesicles in the Pathogenesis of Heart Failure in Patients With Chronic Kidney Disease, Circulation (2026). DOI: 10.1161/circulationaha.125.075579

Comment by Dr. Krishna Kumari Challa yesterday

Exposure to wildfire smoke late in pregnancy may raise autism risk in children

Analysis of over 200,000 births in Southern California indicates that exposure to wildfire smoke during the third trimester of pregnancy is associated with a 23% higher risk of autism diagnosis by age 5. The association is strongest with exposure exceeding 10 days. These findings support concerns about air pollution's impact on fetal neurological development.

Prenatal Exposure to Wildfire and Autism in Children, Environmental Science & Technology (2026). DOI: 10.1021/acs.est.5c08256

Comment by Dr. Krishna Kumari Challa yesterday

Scientists discover a hidden RNA 'aging clock' in human sperm

Increasing paternal age has been linked to elevated health risks for the next generation, including higher risks of obesity and stillbirth. So, what drives this increased risk?

Most research into this link focuses on how the DNA inside sperm changes with age. But sperm carries other molecules as well, including a diverse array of molecules called RNAs.

Now, new research has shown that the RNA contents of sperm go through similar shifts over time in both mice and humans, which may lead to a rapid, dramatic shift at midlife. What's more, "old RNA" seems to change cells' metabolism—potentially contributing to the health risks of having kids later in life.

It's like finding a molecular clock that ticks with age in both mice and humans, suggesting a fundamental, conserved molecular signature of sperm aging.

The researchers were only able to detect some of these changes when they looked at RNA from the sperm head alone—the part of the sperm that delivers its contents to the egg. The long tail of the sperm contains other RNA that obscured the pattern until now.

If we can understand the enzymes driving this shift, they could become actionable targets for interventions to potentially improve sperm quality in aging males.

Conserved shifts in sperm small non-coding RNA profiles during mouse and human aging, The EMBO Journal (2026). DOI: 10.1038/s44318-025-00687-8

• ‹ Previous
• 1
• 2
• 3
• …
• 1174
• Next ›
• Page